SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-291190
Filing Date
2020-11-12
Accepted
2020-11-12 10:05:29
Documents
3
Period of Report
2020-11-09
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d17517d8k.htm 8-K 32458
2 EX-99.1 d17517dex991.htm EX-99.1 97537
3 GRAPHIC g17517avita.jpg GRAPHIC 12237
  Complete submission text file 0001193125-20-291190.txt   148248
Mailing Address 28159 AVENUE STANFORD SUITE 220 VALENCIA CA 91355
Business Address 28159 AVENUE STANFORD SUITE 220 VALENCIA CA 91355 661-367-9170
Avita Therapeutics, Inc. (Filer) CIK: 0001762303 (see all company filings)

IRS No.: 202578762 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39059 | Film No.: 201304255
SIC: 3841 Surgical & Medical Instruments & Apparatus